HEADER ISOMERASE 19-APR-15 5A0E TITLE CRYSTAL STRUCTURE OF CYCLOPHILIN D IN COMPLEX WITH CSA ANALOGUE, JW47. CAVEAT 5A0E ILE B 117 C-BETA WRONG HAND COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F, MITOCHONDRIAL; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPIASE F, 5.2.1.8, CYCLOPHILIN D, CYP-D, CYPD, CYCLOPHILIN COMPND 5 F, MITOCHONDRIAL CYCLOPHILIN, CYP-M, ROTAMASE F; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: JW47; COMPND 11 CHAIN: C, E; COMPND 12 ENGINEERED: YES; COMPND 13 OTHER_DETAILS: CYCLOSPORINE A WITH 1-(PENT-4-ENYL) QUINOLINIUM LINKED COMPND 14 TO THE BMT RESIDUE. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VARIANT: PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: POPINF; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: CYLINDROCARPON LUCIDUM; SOURCE 14 ORGANISM_TAXID: 301100 KEYWDS ISOMERASE, CYCLOPHILIN D, CYP D, PPIF, CYCLOSPORIN A, CSA, JW47, KEYWDS 2 MITOCHONDRIAL PERMEABILITY TRANSITION PORE, PTP, PEPTIDYLPROLYL CIS- KEYWDS 3 TRANS ISOMERASE, CYCLOPHILIN EXPDTA X-RAY DIFFRACTION AUTHOR J.WARNE,G.PRYCE,J.HILL,X.SHI,F.LENNERAS,F.PUENTES,M.KIP,L.HILDITCH, AUTHOR 2 P.WALKER,M.SIMONE,A.W.E.CHAN,G.TOWERS,A.R.COKER,M.DUCHEN, AUTHOR 3 G.SZABADKAI,D.BAKER,D.L.SELWOOD REVDAT 4 10-JAN-24 5A0E 1 LINK REVDAT 3 08-MAY-19 5A0E 1 REMARK LINK REVDAT 2 16-MAR-16 5A0E 1 JRNL REVDAT 1 30-DEC-15 5A0E 0 JRNL AUTH J.WARNE,G.PRYCE,J.HILL,X.SHI,F.LENNERAS,F.PUENTES,M.KIP, JRNL AUTH 2 L.HILDITCH,P.WALKER,M.I.SIMONE,A.W.E.CHAN,G.J.TOWERS, JRNL AUTH 3 A.R.COKER,M.R.DUCHEN,G.SZABADKAI,D.BAKER,D.L.SELWOOD JRNL TITL SELECTIVE INHIBITION OF THE MITOCHONDRIAL PERMEABILITY JRNL TITL 2 TRANSITION PORE PROTECTS AGAINST NEURO-DEGENERATION IN JRNL TITL 3 EXPERIMENTAL MULTIPLE SCLEROSIS. JRNL REF J.BIOL.CHEM. V. 291 4356 2016 JRNL REFN ISSN 0021-9258 JRNL PMID 26679998 JRNL DOI 10.1074/JBC.M115.700385 REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0107 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 75156 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.100 REMARK 3 R VALUE (WORKING SET) : 0.098 REMARK 3 FREE R VALUE : 0.131 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3964 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.28 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5143 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.69 REMARK 3 BIN R VALUE (WORKING SET) : 0.1130 REMARK 3 BIN FREE R VALUE SET COUNT : 297 REMARK 3 BIN FREE R VALUE : 0.1670 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2680 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 304 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.032 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.034 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.020 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.994 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.986 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.980 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2813 ; 0.022 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2712 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3815 ; 2.137 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6263 ; 3.101 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 348 ; 6.765 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 107 ;28.953 ;24.299 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 450 ;11.976 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;17.751 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 425 ; 0.300 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3234 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 626 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1430 ; 2.678 ; 1.185 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1429 ; 2.677 ; 1.184 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1788 ; 3.300 ; 1.786 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1383 ; 4.204 ; 1.500 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5525 ; 6.193 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 95 ;30.806 ; 5.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 5667 ;11.736 ; 5.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 5A0E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-APR-15. REMARK 100 THE DEPOSITION ID IS D_1290063494. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JAN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 2.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9174 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 101898 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.120 REMARK 200 RESOLUTION RANGE LOW (A) : 35.990 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.5 REMARK 200 DATA REDUNDANCY : 11.80 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 45.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.70 REMARK 200 R MERGE FOR SHELL (I) : 1.04000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2Z6W REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: HANGING DROP 50:50. PRECIPITANT: 23% REMARK 280 POLYETHYLENE GLYCOL (PEG3350), 50 MM SODIUM-CITRATE BUFFER AT PH REMARK 280 2.9 PROTEIN: 30 MG/ML IN 50MM POTASSIUM/SODIUM PHOSPHATE PH 7.3, REMARK 280 100MM NACL, 2MM EDTA, 0.02% SODIUM AZIDE., VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 19.06000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.58500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.75500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.58500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 19.06000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.75500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1230 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER B 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLY A 72 CA GLY A 72 C -0.164 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 11 CB - CG - OD1 ANGL. DEV. = 8.4 DEGREES REMARK 500 ASP A 11 CB - CG - OD2 ANGL. DEV. = -7.6 DEGREES REMARK 500 ASP A 27 CB - CG - OD1 ANGL. DEV. = 5.9 DEGREES REMARK 500 MET A 136 CG - SD - CE ANGL. DEV. = 10.5 DEGREES REMARK 500 GLU A 143 OE1 - CD - OE2 ANGL. DEV. = -7.3 DEGREES REMARK 500 ASP B 11 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP B 11 CB - CG - OD2 ANGL. DEV. = -6.0 DEGREES REMARK 500 ILE B 117 CG1 - CB - CG2 ANGL. DEV. = 23.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 60 -82.40 -139.94 REMARK 500 PHE A 129 10.03 -140.61 REMARK 500 PHE B 60 -77.63 -132.15 REMARK 500 THR B 119 57.23 -114.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE (BMT): REMARK 600 1-PENT-4-ENYL QUINOLINIUM LINKED TO CH OF BMT REMARK 600 1-(PENT-4-ENYL)QUINOLINIUM (DRG): LINKED TO CH OF BMT REMARK 999 REMARK 999 SEQUENCE REMARK 999 K133I MUTATION DBREF 5A0E A 1 165 UNP P30405 PPIF_HUMAN 43 207 DBREF 5A0E B 1 165 UNP P30405 PPIF_HUMAN 43 207 DBREF 5A0E C 1 11 PDB 5A0E 5A0E 1 11 DBREF 5A0E E 1 11 PDB 5A0E 5A0E 1 11 SEQADV 5A0E ILE A 133 UNP P30405 LYS 175 ENGINEERED MUTATION SEQADV 5A0E ILE B 133 UNP P30405 LYS 175 ENGINEERED MUTATION SEQRES 1 A 165 SER GLY ASN PRO LEU VAL TYR LEU ASP VAL ASP ALA ASN SEQRES 2 A 165 GLY LYS PRO LEU GLY ARG VAL VAL LEU GLU LEU LYS ALA SEQRES 3 A 165 ASP VAL VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 A 165 CYS THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER THR SEQRES 5 A 165 PHE HIS ARG VAL ILE PRO SER PHE MET CYS GLN ALA GLY SEQRES 6 A 165 ASP PHE THR ASN HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 A 165 TYR GLY SER ARG PHE PRO ASP GLU ASN PHE THR LEU LYS SEQRES 8 A 165 HIS VAL GLY PRO GLY VAL LEU SER MET ALA ASN ALA GLY SEQRES 9 A 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ILE SEQRES 10 A 165 LYS THR ASP TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 A 165 HIS VAL ILE GLU GLY MET ASP VAL VAL LYS LYS ILE GLU SEQRES 12 A 165 SER PHE GLY SER LYS SER GLY ARG THR SER LYS LYS ILE SEQRES 13 A 165 VAL ILE THR ASP CYS GLY GLN LEU SER SEQRES 1 B 165 SER GLY ASN PRO LEU VAL TYR LEU ASP VAL ASP ALA ASN SEQRES 2 B 165 GLY LYS PRO LEU GLY ARG VAL VAL LEU GLU LEU LYS ALA SEQRES 3 B 165 ASP VAL VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 B 165 CYS THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER THR SEQRES 5 B 165 PHE HIS ARG VAL ILE PRO SER PHE MET CYS GLN ALA GLY SEQRES 6 B 165 ASP PHE THR ASN HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 B 165 TYR GLY SER ARG PHE PRO ASP GLU ASN PHE THR LEU LYS SEQRES 8 B 165 HIS VAL GLY PRO GLY VAL LEU SER MET ALA ASN ALA GLY SEQRES 9 B 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ILE SEQRES 10 B 165 LYS THR ASP TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 B 165 HIS VAL ILE GLU GLY MET ASP VAL VAL LYS LYS ILE GLU SEQRES 12 B 165 SER PHE GLY SER LYS SER GLY ARG THR SER LYS LYS ILE SEQRES 13 B 165 VAL ILE THR ASP CYS GLY GLN LEU SER SEQRES 1 C 11 DAL MLE MLE MVA AUX ABA SAR MLE VAL MLE ALA SEQRES 1 E 11 DAL MLE MLE MVA AUX ABA SAR MLE VAL MLE ALA MODRES 5A0E MLE C 2 LEU N-METHYLLEUCINE MODRES 5A0E MLE C 3 LEU N-METHYLLEUCINE MODRES 5A0E MVA C 4 VAL N-METHYLVALINE MODRES 5A0E ABA C 6 ALA ALPHA-AMINOBUTYRIC ACID MODRES 5A0E SAR C 7 GLY SARCOSINE MODRES 5A0E MLE C 8 LEU N-METHYLLEUCINE MODRES 5A0E MLE C 10 LEU N-METHYLLEUCINE MODRES 5A0E MLE E 2 LEU N-METHYLLEUCINE MODRES 5A0E MLE E 3 LEU N-METHYLLEUCINE MODRES 5A0E MVA E 4 VAL N-METHYLVALINE MODRES 5A0E ABA E 6 ALA ALPHA-AMINOBUTYRIC ACID MODRES 5A0E SAR E 7 GLY SARCOSINE MODRES 5A0E MLE E 8 LEU N-METHYLLEUCINE MODRES 5A0E MLE E 10 LEU N-METHYLLEUCINE HET DAL C 1 5 HET MLE C 2 9 HET MLE C 3 9 HET MVA C 4 8 HET AUX C 5 25 HET ABA C 6 6 HET SAR C 7 5 HET MLE C 8 9 HET MLE C 10 9 HET DAL E 1 5 HET MLE E 2 9 HET MLE E 3 9 HET MVA E 4 8 HET AUX E 5 25 HET ABA E 6 6 HET SAR E 7 5 HET MLE E 8 9 HET MLE E 10 9 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM AUX 4-METHYL-4-[8-QUINOLINIUM-4-ENE]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM SAR SARCOSINE FORMUL 3 DAL 2(C3 H7 N O2) FORMUL 3 MLE 8(C7 H15 N O2) FORMUL 3 MVA 2(C6 H13 N O2) FORMUL 3 AUX 2(C21 H29 N2 O3 1+) FORMUL 3 ABA 2(C4 H9 N O2) FORMUL 3 SAR 2(C3 H7 N O2) FORMUL 5 HOH *304(H2 O) HELIX 1 1 VAL A 29 GLY A 42 1 14 HELIX 2 2 THR A 119 ASP A 123 5 5 HELIX 3 3 GLY A 135 SER A 144 1 10 HELIX 4 4 VAL B 29 GLY B 42 1 14 HELIX 5 5 THR B 119 ASP B 123 5 5 HELIX 6 6 GLY B 135 PHE B 145 1 11 SHEET 1 AA 8 PHE A 53 ILE A 57 0 SHEET 2 AA 8 MET A 61 ALA A 64 -1 O MET A 61 N ILE A 57 SHEET 3 AA 8 PHE A 112 CYS A 115 -1 O PHE A 112 N ALA A 64 SHEET 4 AA 8 VAL A 97 MET A 100 -1 O VAL A 97 N CYS A 115 SHEET 5 AA 8 VAL A 128 GLU A 134 -1 N PHE A 129 O LEU A 98 SHEET 6 AA 8 LYS A 15 LEU A 24 -1 O VAL A 21 N ILE A 133 SHEET 7 AA 8 LEU A 5 ALA A 12 -1 O VAL A 6 N LEU A 22 SHEET 8 AA 8 VAL A 157 GLN A 163 -1 O VAL A 157 N ASP A 11 SHEET 1 BA 8 PHE B 53 ILE B 57 0 SHEET 2 BA 8 MET B 61 ALA B 64 -1 O MET B 61 N ILE B 57 SHEET 3 BA 8 PHE B 112 CYS B 115 -1 O PHE B 112 N ALA B 64 SHEET 4 BA 8 VAL B 97 MET B 100 -1 O VAL B 97 N CYS B 115 SHEET 5 BA 8 VAL B 128 GLU B 134 -1 N PHE B 129 O LEU B 98 SHEET 6 BA 8 LYS B 15 LEU B 24 -1 O VAL B 21 N ILE B 133 SHEET 7 BA 8 LEU B 5 ALA B 12 -1 O VAL B 6 N LEU B 22 SHEET 8 BA 8 ILE B 156 GLN B 163 -1 O VAL B 157 N ASP B 11 LINK C DAL C 1 N MLE C 2 1555 1555 1.35 LINK N DAL C 1 C ALA C 11 1555 1555 1.32 LINK C MLE C 2 N MLE C 3 1555 1555 1.39 LINK C MLE C 3 N MVA C 4 1555 1555 1.34 LINK C MVA C 4 N AUX C 5 1555 1555 1.34 LINK C AUX C 5 N ABA C 6 1555 1555 1.33 LINK C ABA C 6 N SAR C 7 1555 1555 1.35 LINK C SAR C 7 N MLE C 8 1555 1555 1.27 LINK C MLE C 8 N VAL C 9 1555 1555 1.33 LINK C VAL C 9 N MLE C 10 1555 1555 1.31 LINK C MLE C 10 N ALA C 11 1555 1555 1.33 LINK C DAL E 1 N MLE E 2 1555 1555 1.34 LINK N DAL E 1 C ALA E 11 1555 1555 1.37 LINK C MLE E 2 N MLE E 3 1555 1555 1.37 LINK C MLE E 3 N MVA E 4 1555 1555 1.34 LINK C MVA E 4 N AUX E 5 1555 1555 1.35 LINK C AUX E 5 N ABA E 6 1555 1555 1.35 LINK C ABA E 6 N SAR E 7 1555 1555 1.37 LINK C SAR E 7 N MLE E 8 1555 1555 1.30 LINK C MLE E 8 N VAL E 9 1555 1555 1.29 LINK C VAL E 9 N MLE E 10 1555 1555 1.35 LINK C MLE E 10 N ALA E 11 1555 1555 1.31 CRYST1 38.120 69.510 109.170 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026233 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014386 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009160 0.00000